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ABSTRACT
HIV incubation period is the random time between the HIV-infection 
and the onset of clinical AIDS. Distribution of this non-negative 
random variable is known as HIV incubation period distribution. The 
Back-calculation method reconstructs the past pattern of HIV 
infection and predicts the future number of AIDS cases with the 
present infection status. It depends on three important factors: 
incubation distribution, incidence curve and observed number of 
AIDS cases over time. This method is very popular and requires less 
information and assumptions. Lack of information about incubation 
distribution, the effect of intervention therapy on incubation period, 
and errors in reported AIDS incidence leads to uncertainties 
associated with this method.  The incubation distribution is assumed 
to be exactly known in back-calculation methodology. Incubation 
period of HIV is very long and highly variable within and between 
cohorts. The current prevalence of HIV-infection and the 
corresponding pattern of incidence from the beginning of the 
epidemic to the present time are mainly estimated by means of back-
calculation method. It calculates the most likely temporal distribution 
of infected individuals compatible with the number of observed 
AIDS cases starting from the suitable estimate of the incubation 
period, derived from the available data. Most of the projections 
formulated the problem of estimation of future AIDS cases as 
estimation of parameters in multinomial likelihood with unknown 
sample size by EM algorithm. In this paper the various approaches for 
modeling the incubation distribution are compared using real and 
simulated data under various infection density distributions. The 
projected minimum AIDS cases in India based on the reported data 
for the years 2003, 2004, 2005 and 2006 are around 27000, 44000, 70000 
and 113000 respectively. The corresponding figures based on the 
adjusted data are around 67000,100000,150000 and 230000 respectively. 
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INTRODUCTION
The Acquired Immune Deficiency 
Syndrome (AIDS) is a devastating 
disease caused by Human Immune 
deficiency Virus (HIV) that is transmitted 
through either sexual, other contacts in 
which body fluids are exchanged or using 
infected blood products Following a few 
recognized cases among homosexual 
men in the United States in the year 1981, 
new cases of AIDS were subsequently 
reported in a many countries throughout 
the world.  It has now reached a 
pandemic proportion, as no country in 
the world is now free from HIV/AIDS. 
This epidemic ranks as one of the most 
destructive microbial scourges in human 
history and has posed a formidable 
challenge to the biomedical research and 
public health communities of the world.
The global pandemic of HIV infection 
comprises many different epidemics, 
each with its own dynamics e.g., time of 
introduction, population density, 
cultural and social issues. Spread of the 
epidemic has varied considerably 
between developed and developing 
countries, depending on the culture as 
well as other social and behavioral 
patterns. Incidence rates have been the 
highest in developing countries where 
heterosexual transmission is most 
common.
First case of AIDS was reported in India 
in the year 1986. Now India's entry into 
the third phase of the HIV epidemic, as 
envisaged from the increasing number of 
HIV infections detected even among 
housewives and children, signals major 
AIDS crisis in the offing. The first phase of 
. 
HIV was recognized when rising trend of 
HIV prevalence was established among 
the Commercial Sex Workers (CSW) in 
1988 and the professional blood donors in 
1989. The second phase started after 1989 
when several of the clients of CSW and 
blood recipients were found to be 
infected.
BIOLOGICAL ASPECTS OF HIV/AIDS 
AND ITS TRANSMISSION
AIDS is a condition in which the in built 
immune mechanism of the human body 
breaks down completely. The process is 
gradual but ultimately suppresses the 
immune ability of the individuals. It is a 
medically accepted fact that the HIV is the 
causal agent of AIDS. Those who are 
affected by AIDS are susceptible to other 
opportunistic infections like Candida, 
Mucor Omycosis and Aspergillus etc
Within a few weeks of its entry into the 
blood stream of an individual, the HIV 
sets an insidious and progressive attack 
on the immune system of the individual 
by binding itself to one of the T4 helper 
cells. The viral attachment to the cell is 
initiated by means of antibodies to the 
virus. On infecting the T4 cell, the viral 
RNA is injected into the target cell along 
with viral transcriptase and viral 
integrase. The viral reverse transcriptase 
transcribes the viral RNA into viral DNA 
and the viral integrase bind the viral 
DNA with that of the host. The integrated 
viral DNA may remain latent or in an 
activated form. In the activated form, 
genomic RNA and messenger RNA are 
transcribed from the integrated viral 
DNA.  The regulatory proteins such as tat 
and rev are translated from messenger 
.
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RNA. These proteins together with the 
genomic RNA cause the production of 
new HIV viruses, which bud on the cell 
wall. These buds accumulate on the cell 
wall and after a random length of time 
from the time of infection, the infected 
cell disintegrates (i.e. the cell undergoes a 
lyses) releasing a random number of HIV 
viruses and this process continues 
indefinitely. This mechanism by which 
the killing of the T4 cells takes place, the 
number of free virus in the blood 
destroys progressively the immune-
competence of the host. The viral load 
(the amount of free HIV in the blood) 
increases following infection and peaks 
at the time of sero-conversion (i.e. the 
time at which detectable levels of 
antibodies develop in the blood) and falls 
to a level (called set-point) by about 2 
years thereafter and then remains at that 
level throughout the asymptomatic 
period. A low level of set point 
corresponds to a low risk of AIDS and a 
high level of set point corresponds to a 
high risk of AIDS. The viral load 
measured at arbitrary base line is a good 
prognostic marker at all stages of the 
development of AIDS.  On the other 
hand, the T4 cell counts in the blood 
decrease rapidly in the initial months 
following infection and thereafter at a 
slower rate. After a period of several 
years, when the level of T4 cells declines 
3
to roughly 400 cells/mm the person 
, 
exhibits symptoms and signs associated 
with HIV disease. These symptoms and 
signs do not meet the surveillance 
definition of AIDS and we say that the 
person is suffering from AIDS related 
complex (ARC). The level of T4 cells 
further continues to decrease to roughly 
3 
below 200 cells/mm and AIDS defining 
diseases such as Kaposi's sarcoma and 
Pneumocystis carinii pneumonia occur. At 
this stage, the patient is said to have 
developed AIDS.
APPROACHES FOR HIV/AIDS 
MODELING
In general,  HIV/AIDS epidemic 
modeling is categorized based on the 
following four broad approaches but not 
1
mutually exclusive ones .
Deterministic Models: In this type of 
modeling the parameters such as number 
of susceptible individuals, infected 
individuals and number of AIDS cases 
are assumed to be deterministic. These 
models are described by system of 
differential or integral equations. The 
progression of the epidemic is studied 
using these equations. Some of the 
deterministic models for AIDS epidemic 
2-7
were developed . 
Stochastic Models: Stochastic models 
assume that some of the key parameters 
are random variables. It is assumed that 
the HIV epidemic is a continuous time 
stochastic process. Stochastic models are 
considered to be more realistic than 
deterministic models and with some 
special assumptions the results of 
d e t e r m i n i s t i c  m o d e l s  c a n  b e  
approximated through stochastic 
models. But there are studies, which 
show that stochastic models give a better 
interpretation of the epidemic than the 
8-11
deterministic models . 
Statistical models: The statistical models 
a r e  d e v e l o p e d  b a s e d  o n  A I D S  
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epidemiological and survey data. These 
models make full use of the available data 
compared to deterministic and stochastic 
models. But in this type of modeling the 
mechanism and prior information system 
is usually not taken into consideration. 
The back-calculation approach for 
HIV/AIDS projection can be categorized 
12-14
into this type of modeling . 
15
State Space Models: Wu and Tan (1995)  
have introduced the state space models 
for AIDS epidemic, which takes the 
advantage of stochastic and statistical 
models. The state space models were 
16
originally proposed  for engineering 
control and communication. This model 
10-11,17 
is also used in projection and detailed 
description of the state space models is 
1
given by Tan (2000)  .
PROJECTION OF HIV/AIDS
Projections of HIV/AIDS using the 
statistical modeling approach are done 
based on the following three methods :(i).
Fitting a model to the incidence of 
HIV/AIDS and extrapolating the curves 
18
into the future . The estimates obtained 
using this method depends on the 
mathematical function used and hence 
some function can produce anomalous 
results. This method is also less efficient 
as this does not include important 
information on the epidemic like 
incubation period, infection density and 
nature of the spread of the epidemic.(ii).
The next approach is based on modeling 
19-20
the dynamics of the epidemic . This 
approach requires certain knowledge 
about mixing pattern of HIV individual 
with probabilities of infection per contact, 
size of high risk behavior group, 
 
 
probabilities of infection through blood 
product,  needle sharing etc.  In 
developing countries like India, 
knowledge about these key parameters is 
incomplete. Also stochastic modeling of 
the epidemic demands many parameters, 
which are generally difficult to estimate 
due to limitation of appropriate data 
especially in the Indian context. There is a 
lot of literature on deterministic and 
stochastic models for the spread of HIV 
1
epidemic . (iii). One of the most popular 
method used for projection of HIV/AIDS 
21-22
is the back calculation method . This 
method is used to reconstruct the past 
pattern of HIV infection and to predict the 
future number of AIDS cases, apart from 
knowing the present infection status. This 
method depends on three important 
factors namely, the incubation period 
distribution, incidence curves and the 
observed number of AIDS cases over a 
time period. There are also uncertainties 
associated with this approach because 
lack of certain information about 
incubation period distribution, the effect 
of intervention therapy on incubation 
period and errors in reported AIDS 
incidence. However back calculation 
method is very popular, as it requires few 
information and assumptions and thus 
easy to apply.
Back-calculation Methodology
The back calculation method for short-
term projection of AIDS epidemic was 
21-22
introduced .  The infection rate 
represents the number of new HIV 
infections per unit time at calendar time. 
Sero-conversion refers to infected 
individuals remain sero-negative until 
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they develop detectable HIV antibodies. 
The sero-conversion period is usually 
short and it has a median of 2 to 3 months. 
The incubation period is the time 
duration between sero-conversion to 
AIDS. The incubation periods are highly 
variable across groups. Several models 
for incubation period distribution are 
used to describe the incubation period.
This method uses a form of infection 
curve, either parametric or non-
parametric, for the number of past HIV 
infections or equivalently a density 
23-24
function for HIV infections .  The time 
between HIV infection and the diagnosis 
of AIDS is known as incubation time and 
it is modeled by a known distribution. 
Future AIDS incidence can be projected 
by the estimated infection curve and the 
known incubation distribution. 
Most of the research on the projection of 
AIDS epidemic is based on the back 
13-14,25
calculation method . There are 
various sources of uncertainties 
14,26
associated with the estimates of AIDS  
based on back-calculation method.  
Major sources of uncertainties may be 
due to the inaccuracies of reported AIDS 
cases, the assumptions about the 
incidence curve and the incubation 
distribution. The inaccuracies in the 
reported AIDS cases may be due to the 
reporting delays, under diagnosis and 
underreporting. Reporting delays of 
13,27-
AIDS incidence has also been modeled
28 29
. It was observed  that only a few studies 
address the problem of underreporting. 
Various forms of incidence curves and 
s e v e r a l  p a r a m e t r i c  i n c u b a t i o n  
distributions have been used in the 
literature. Uncertainties of AIDS 
incubation time and its effect on back 
30-31
calculation estimates are discussed . 
The methodology to include information 
from the results of surveillance to 
improve the accuracy of projection of 
AIDS cases was given by Bellico and 
32
Marschner . Bayesian approaches for 
AIDS projection have also received a lot 
33-34
of attention . Swaminathan et al., 
35
(2000)  presented the survival experience 
of a group of HIV patients. Venkatesan 
3 6
( 2 0 0 2 )  d i s c u s s e d  t h e  v a r i o u s  
mathematical and statistical approaches 
for projection of HIV/AIDS epidemic. 
Projections using back calculation 
37
method are explored . In this work we 
h a v e  c o n c e n t r a t e d  m a i n l y  o n  
understanding the current state of 
epidemic and forecasting the future path 
via back calculation method. The broad 
objective is to provide HIV/AIDS 
estimates under different model 
assumptions using surveillance data for 
India.
Models for Incubation Period
The HIV incubation period is the random 
time between the HIV infection and the 
onset of clinical AIDS symptoms. The 
probability distribution of this non-
negative random variable is known as 
HIV incubation period distribution. 
38
Medley et al. (1987)  showed that the 
incubation period of HIV is known to be 
very long and it is highly variable within 
and between cohorts.
The analysis of incubation period is very 
important in AIDS epidemic studies. 
Incubation period distribution is 
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assumed to be exactly known in back 
calculation methodology. Several studies 
1,6,13-14,26,39-41
 have observed that back 
calculation estimates are very sensitive to 
the choice of incubation period 
distribution., It has also been shown that
the HIV incubation distribution is 
significantly affected by age, treatment 
b y  a n t i v i r a l  d r u g s  a n d  o t h e r  
42-48
opportunistic infections . Hence for 
estimation of the HIV infection and 
projection of future HIV prevalence and 
AIDS, it is very important to study the 
HIV incubation distribution under 
different conditions.
The incubation period models are similar 
to survival models based on non-
negative random variables and can be 
fitted using either parametric or Semi-
parametric approach. A review of some 
of the parametric models for incubation 
period is discussed below.
Weibull and Gamma Models: Weibull 
and gamma models are the most 
commonly used for many real data 
applications and in particular for back 
calculation approach. Between the two, 
Weibull model is a popular candidate for 
HIV incubation period because of its nice 
properties viz., it is proportional hazard 
as well as accelerated failure time model. 
The Weibull distribution function is 
given by
–(l t) a
F (t) = 1 – e   l > 0, a > 0 and t > 0   (1)
The earliest studies of Weibull incubation 
38,49
period have been attempted  and fitted 
Weibull model to study the incubation 
period distribution for transfusion 
 
associated AID cases
0.0243.t 2.286
F (t) = 1 – e  (2)
These parameter values correspond to a 
median incubation period of 4.3 years. 
The incubation period of patients 
infected by blood transfusion was 
38
studied  using Weibull distribution for 
Children (0-4years) and estimated the 
parameters as follows; a=1.9390, 
al =0.1566, for others (5-59 years) as 
a 50a=2.3960, l =0.0048. Boldson et al.  used 
gamma, Weibull and log-normal models 
for incubation time of cohort study from 
San Francisco AIDS cases. The fitted 
Weibull model for their data is given by
2.5
F (t) = 1 – exp (–0.001296 t ) (3)
The Weibull HIV incubation model used 
by Anderson et al. (1986) is given by
1.9974
F (t) = 1 – exp (–0.1190 t ) (4)
51
Brookmeyer and Goedert  used the 
Weibull incubation period distributions 
based on the study of hemophiliacs over 
20 years of age. The fitted Weibull model 
for their data is given by
2.516 
F (t) = 1 – e –0.0021 t (5)
This estimate corresponds to a median 
incubation of 10 years. 
Based on 732 HIV-positive hemophiliacs 
enrolled in Italian registry, Chiarotti et 
5 2
a l .  e s t i m a t e d  t h e  i n c u b a t i o n  
distributions assuming three different 
parametric models: uniform, uniform in 
three sub intervalsand truncated Weibull 
 
under two approaches namely the 
median and median of three random 
values. There are altogether six different 
approaches to estimate the incubation 
time of individuals. They found that the 
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incubation times obtained using first and 
third are similar. Therefore they reported 
only four estimates. The estimates of the 
four models parameters are a=2.9, 2.4, 2.9, 
a
2.6 and l =0.003668, 0.001039, 0.000446, 
0.000845. The median incubation time are 
13.5, 15, 12.6 and 13.3 respectively.
53
Munoz and Xu  using Multicenter AIDS 
Cohort Study (MACS) estimated this 
Weibull model.
–0.052087 t 1.285347 
F (t) = 1 – e (6)
The median incubation period using this 
model is 7.5 years. Other important 
studies also used the Weibull model for 
8,39,41,54
HIV incubation period . 
The gamma distribution is another 
important parametric distribution used to 
model incubation period of HIV/AIDS. 
The gamma density function is
(7)
38
One of the earliest studies  that used 
gamma model for incubation period of 
HIV estimated parameter for the gamma 
models are as follows. K=2.669, 2.473 and 
a=0.911 and 11.001. The parameters 
50
estimated from gamma model  based on 
the San Francisco AIDS data gave 
k = 3.130 and = 5.715 years. Freund and 
55
Book  fitted gamma model with k = 3 
(Erlang form) to the San Francisco AIDS 
data and the estimate obtained for the 
parameter  s= 2.660 years.
Log-logistic and Log-normal models: 
56
Lawless and Sun  used the log-logistic 
model for HIV incubation period, in 
52
addition Chiarotti et al.  used log-logistic 
model and generalized exponential 
model for their data. The log-normal 
50,57
distribution has been used  for HIV 
53,58
incubation period. Recent studies  have 
shown that lognormal distribution fits 
well than Weibull model.
The log-logistic distribution function is
(8)
The distribution function of lognormal is
(9)
where
The distribution function generalized 
log-logistic is
(10)
The generalized log-logistic distribution 
reduces to log-logistic distribution when  
59-60
This has been shown  that the three 
parameters generalized log-logistic 
distribution with fits better than the log-
logistic distribution for data on cancer 
61
survival analysis. Stacy  introduced a 
generalization of gamma distribution 
with three parameters. This model is a 
generalization of many survival 
distributions. The convolution of 
exponential distribution has been used as 
incubation model for HIV.
62
Longini et al.  used a staged Markov 
model to estimate the distribution and 
mean length of the incubation period 
from a cohort study of 603 HIV infected 
individuals who have been followed 
through various stages of infection. They 
used the generalized gamma model to 
describe the transition probabilities of the 
Markov model. 
Mixture and Staging Model: One way to 
accommodate the variation between 
different groups of the population is by 


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


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using mixture models. Suppose certain 
proportions of infected individuals  have 
an incubation period distribution and the 
remaining proport ion have  the  
incubation period distribution. Then the 
incubation period distribution for the 
entire population of infected individuals 
is a mixture of  and  is given by
(11)
63
Auger et al.  considered a mixture of two 
Weibull densities for the incubation 
period of Paedictric AIDS cases. The 
49
mixture of two Weibull distributions  
was also used in a study of incubation 
period distribution of sample individuals 
drawn from San Francisco AIDS data.
The convolution equation for the 
incubation period comprising of  two 
stages given by Brookmeyer and Liao 
(1990) is
(12)
where
(13)
(14)
Suitable changes should be made in the 
above formulations to account for 
calendar time of infection. Under staging 
models the incubation period is 
considered to be comprised of stages. The 
progression from time of infection to 
64
AIDS was assumed to occur in 3 stages . 
The stage 1 refers to HIV infection 
without immunological abnormalities, 
stage 2 is the development of pre-AIDS 
10              )()1()()(
21
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disease and stage 3 is the development of 
clinical AIDS. The incubation time of an 
individual by definition is the total time 
spent on stage 1 and stage 2.Therefore 
different models for these two stages can 
be assumed.  Suppose the times spent on 
the two stages are not independent, then 
the time spent on the stage 2 can be 
conditioned on the time spent on stage 1. 
26
Under this case Mariotti and Cascioli  
have given the survival functions for the 
second stage.
Change Point and Contact Models: A 
change point model and contact model 
for incubation period of HIV was 
65
proposed . Suppose the incubation time 
for an individual is t. It is reasonable to 
assume that between 0 to t, there is a time 
point  at which the hazard of incubation 
changes. The point  may be the time after 
infection when the individual realizes the 
threat of AIDS and seeks some kind of 
medication. Suppose the hazard before 
and after the change point is constant, 
then h (t) is given by
(15)
The survival function of the above 
change point model is given by
(16)
The other types of hazards considered 
were varying hazard and Weibull 
hazard. 
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A model for incubation time using the 
concept of contacts to immune system 
uses the random contact concept for 
formulation.  Suppose at time t = 0, a 
member tested for HIV positive for the 
first time, experiences a random N 
number of contacts to the immune 
system before he shows clinical 
symptoms to AIDS. The number of 
contacts N experienced by the individual 
is assumed to follow a Poisson process 
with parameter l(>0). We assume that 
the system undergoes at least one 
invasion before the individual become 
AIDS in  ( t , tD t ) .  Using Laplace  
transformation and simple algebra we 
obtain the distribution function for an 
individual to become AIDS can be 
obtained as
(17)
If l=m=, then
(18)
(19)
It can be noted that the hazard rate is 
increasing function of t. The median of 
the distribution can be obtained 
numerically by solving (17). The 
parameters of  can be estimated by using 
the method of maximum likelihood.
BACK-CALCULATION ESTIMATES 
OF HIV/AIDS IN INDIA
The National AIDS Control Organization 
66
(NACO)  publishes periodic estimates of 
HIV/AIDS based on its own projections 
and also the reports of UNAIDS and 
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WHO. NACO also publishes the reported 
number of AIDS cases in India as well as 
in states and union territories in India.  In 
1986, the reported number of AIDS cases 
was 6 and in 2002, the number increased 
to 19324.The estimates published by 
various other agencies regarding the total 
number of HIV/AIDS cases in India 
seemed to be over estimated according to 
the many researchers. An attempt has 
been made in this work to give the 
estimates of the minimum number of 
people living with HIV/AIDS in India. 
We have taken 2002 as the base period and 
estimated the AIDS cases that will be 
reported to the system in the next four 
years. The estimated figures are 
compared with the observed ones for 
2003, 2004 and 2005. 
The basic data required for back 
calculation methodology is the number of 
AIDS cases over a period of time. NACO 
publishes monthly updates of the 
reported AIDS cases for the past few 
years. The monthly updates of the recent 
years also suffer reporting delay and 
therefore pooled yearly reported AIDS 
cases assumed to be more reliable. 
Moreover the data compiled by NACO is 
at unequal time intervals. Therefore in the 
present study only yearly reported AIDS 
cases were considered for projections.
The starting point of the infection T  is 
0
taken to be 1980 for India. Ten incubation 
period distributions are used in the 
present projection of AIDS cases in India. 
The estimates of minimum size of the 
epidemic and future number of AIDS 
cases are obtained assuming different 
median incubation periods. For the 
)1()(
t
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When median incubation= 8 years
Weibull 4243202 280156 26795 43327 70060 113286
Gamma 3023853 160377 26841 43433 70282 113728
Log-logistic 4141256 301222 26797 43332 70069 113302
Log-normal 4378305 249908 26816 43375 70159 113482
Generalized Exponential 4446099 146690 26846 43444 70304 113771
Generalized Log-logistic 4052072 306432 26680 43035 69410 111944
Generalized Gamma 3624674 146772 26840 43432 70279 113721
Mixed Weibull 4219371 280259 26789 43321 70050 113280
Change Point 4287475 279968 26780 43325 70065 113289
Immune Invasion 2917156 175218 26829 43406 70226 113616
When median incubation= 10 years
Weibull 4681218 444462 26745 43265 69925 113013
Gamma 3814500 255189 26824 43394 70199 113561
Log-logistic 4104232 488436 26766 43258 69911 112987
Log-normal 4250104 385640 26753 43326 70055 113273
Generalized Exponential 4613632 251003 26826 43398 70206 113576
Generalized Log-logistic 4706203 550776 26676 43023 69383 111885
Generalized Gamma 4074022 199972 26832 43412 70237 113638
Mixed Weibull 4730853 443742 26731 43242 69927 113007
Change Point 4732736 442925 26725 43235 69919 113020
Immune Invasion 3912703 255182 26816 43374 70158 113479
When median incubation= 12 years
Weibull 5069775 657874 26750 43216 69820 112799
Gamma 4219708 405246 26804 43345 70095 113352
Log-logistic 4630203 750856 26736 43186 69757 112675
Log-normal 4964605 570339 26774 43275 69945 113052
Generalized Exponential 5412150 451076 26795 43325 70052 113266
Generalized Log-logistic 5144634 883083 26674 43018 69369 111856
Generalized Gamma 4708975 259962 26825 43396 70203 113568
Mixed Weibull 5070029 653421 26732 43208 69815 112810
Change Point 4908890 660570 26724 43251 69803 112893
Immune Invasion 4253183 353892 26805 43348 70099 113362
When median incubation= 15 years
Weibull 5293098 1093251 26729 43165 69704 112560
Gamma 4362512 812829 26763 43249 69888 112935
Log-logistic 4447016 1320676 26698 43091 69550 112254
Log-normal 5210566 965345 26741 43197 69777 112713
Generalized Exponential 6078422 1185040 26714 43130 69634 112423
Generalized Log-logistic 6585507 1585456 26672 43013 69359 111834
Generalized Gamma 5215866 365798 26817 43376 70160 113483
Mixed Weibull 5246183 1081218 26732 43171 69716 112585
Change Point 5323427 1105845 26748 43210 69689 112645
Immune Invasion 4661770 534254 26793 43319 70037 113235
Table 1. Estimates of HIV incidence and projection of AIDS under logistic prevalence 
infection density  
Incubation Model
Projection of AIDS
2003 2004 2005 2006
Incidence
in 2002
Nˆ
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Incubation Model
Projection of AIDS
2003 2004 2005 2006
Incidence
in 2002
Nˆ
Table 2. Estimates of HIV incidence and projection of AIDS under logistic prevalence 
infection density (adjusted for under-reporting and delay in reporting)
When median incubation= 8 years
Weibull 4580854 561695 66495 100801 152786 231785
Gamma 4042568 356453 66735 101312 153795 233433
Log-logistic 4752540 598002 66504 100819 152832 231671
Log-normal 4505245 512988 66601 101031 153241 232415
Generalized Exponential 3952652 330758 66756 101368 153902 233646
Generalized Log-logistic 4589124 545150 65874  99305 149699 225625
Generalized Gamma  3952681 323395 66732 101302 153772 233428
Mixed Weibull 4253141 562326 66510 100789 152764 231574
Change Point 4650115 561549 66502 100795 152799 231602
Immune Invasion 4101854 375978 66677 101172 153521 232975
When median incubation= 10 years
Weibull 4852649 867059 66356 100475 152148 230404
Gamma 4953246 546248 66644 101102 153374 232676
Log-logistic 4858625 935054 66341 100446 152125 230375
Log-normal 4751689 765549 66495 100786 152751 231516
Generalized Exponential 4152645 538489 66623 101115 153416 232748
Generalized Log-logistic 4925448 975477 65818  99242 149575 225354
Generalized Gamma 4251006 434145 66685 101202 153566 233025
Mixed Weibull 4556245 867121 66355 100486 152164 230417
Change Point 4854662 864987 66341 100457 152149 230429
Immune Invasion 4526488 536745 66601 101004 153198 232317
When median incubation= 12 years
Weibull 5145678 1258796 66244 100228 151654 229441
Gamma 5215674 834486 66526 100855 152898 231755
Log-logistic 5043259 1395541 66195 100129 151442 229072
Log-normal 4921486 1099115 66374 100527 152255 230605
Generalized Exponential 4658415 912247 66487 100741 152702 231411
Generalized Log-logistic 5428503 1560546 65822 99218 149514 225243
Generalized Gamma 4628457 558025 66641 101105 153399 232712
Mixed Weibull 4856477 1253741 66258 100242 151674 229486
Change Point 4958115 1261146 66205 100266 151408 229454
Immune Invasion 4726489 733543 66533 100872 152914 231798
When median incubation= 15 years
Weibull 5891562 2051215 66124  99965 151089 228348
Gamma 5945188 1576427 66318 100389 151933 229987
Log-logistic 5518246 2370985 65987  99662 150521 227314
Log-normal 5258995 1788556 66218 100759 151524 229216
Generalized Exponential 5348926 2146419 66074  99847 150897 228005
Generalized Log-logistic 6654897 2796984 65818  99201 149451 225142
Generalized Gamma 4854981 775325 66602 101014 153187 232311
Mixed Weibull 5624189 2037019 66134  99987 151132 228438
Change Point 5548050 2065756 66111  99956 151021 228315
Immune Invasion 5218227 1091589 66465 100714 152605 231204
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incubation period models Weibull, 
Gamma, log-logistic, log-normal and 
generalized exponential distribution 
prior estimates of their parameters were 
available. All these models have only two 
parameters and therefore one parameter 
was fixed based on the estimates 
available in the literature. The parameters 
of  the  general ized log- logis t ic ,  
generalized gamma, mixed Weibull, 
change point and immune invasion level 
models were not available in the 
literature. Therefore parameters of these 
models were decided based on a 
simulation study. 
The backcalculation estimates were 
obtained using the conditional likelihood 
approach for the multinomial likelihood 
with unknown sample size. Although EM 
22
algorithm  can also be used, it has been 
24
observed  that both of the approaches 
yield almost similar estimates. Also the 
condit ional  l ikel ihood approach 
converges at much faster rate and is easy 
to implement in a computer algorithm. 
SAS IML programming was done for the 
actual computation of the estimates. Non-
linear optimization routines were 
extensively used for maximization of the 
conditional likelihood. The calculations 
were repeated under logistic incidence, 
double exponential and root exponential 
for the different median incubation 
period distributions. The estimates of the 
minimum number of HIV cases (), HIV 
incidence for 2002 and short-term 
projection for next 4 years for four 
median times under logistic prevalence 
are presented in the Table 1.
Adjustments for Reporting Delays and 
Under-Reporting:
According to WHO Global HIV/AIDS 
67
Survey , the level of under reporting in 
the South-Eastern Asian Countries 
including India is about 80%. The various 
small studies conducted in different parts 
of India reported the level of under-
reporting between 50% - 95 %. Vandal 
6 8
and Remis  used  75% upward 
adjustment for projections for Canada 
surveillance data. In this work we assume 
90% under-reporting during 1986-87 and 
it decreases to 60% in 2001-02 in an 
exponential decay form. The upward 
adjustments for different years are carried 
out. The reporting delays were modeled 
by many authors. In this work we have 
69
used the approach proposed . The over-
dispersed Poisson regression model with 
68
modifications as adopted  for the 
reporting delays was used and the 
adjusted figures are used for recalculating 
the estimates under the above model 
assumptions,  median incubation 
distributions and infection curves. If the 
adjusted AIDS counts are taken to the 
upper bound of the under reporting and 
delay in reporting, the figure in the 
estimates give the upper limit of the 
number of cases expected. The adjusted 
estimates of the minimum number of HIV 
cases (), HIV incidence for 2002 and short-
term projection for next 4 years for four 
median times under logistic prevalence 
are presented in the Table 2.
DISCUSSION 
It is generally observed that the short term 
projected AIDS cases do not vary much 
across various infection densities and 
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incubation period distributions. But the 
minimum size of the epidemic and HIV 
incidences are highly variable across the 
infection densities and incubation period 
distributions.  The projected AIDS cases 
within a infection density across various 
incubation distributions are found to be 
very stable. But across the infection 
densities the variation is observed to be 
high.  The projected AIDS cases using the 
log-logistic and root exponential 
infection densities are less compared to 
the estimates obtained using the other 
four infection densities.  The projected 
AIDS estimates obtained using the four 
infection densities logistic prevalence, 
logistic incidence, exponential and 
double exponential  seems to be more 
plausible compared to the estimates 
obtained using the other two models 
since the observed AIDS cases in the year 
2000 were nearly 20000.  Hence based on 
the four infection densities and 10 
incubation period distributions with four 
possible median incubation periods 
(several possible combinations for the 
parameters of these distributions), we 
infer that the projected AIDS cases in 
India for the years 2003, 2004, 2005 and 
2006 will be approximately around 27000, 
43500, 70000 and 113500 respectively.  It 
is to be noted that these estimates are 
based on the unadjusted AIDS incidence 
data. These estimates may not be the 
correct number of AIDS cases that may 
develop in India during these periods.  
The exact number of AIDS cases that may 
develop in India will be certainly higher 
than these figures and hence these figures 
can be taken to be a lower bound for 
possible number of AIDS cases. The HIV 
incidence reported for the year 2002 is 
calculated based on the relationship 
between the infection density and the 
infection or incidence curves.  These 
figures are found to be highly variable 
and are not smoothed estimates. Hence 
these figures cannot be taken as exact 
number of HIV incidence in the year 2002.  
The minimum size of the epidemic  
denotes the total number of people who 
may ultimately become AIDS cases even 
if the new infections are currently 
stopped.  Hence this figure can be taken 
to be the number of people living with 
HIV/AIDS in India and the adjusted 
AIDS counts can be taken to the upper 
bound. For all combinations of eight 
infection densities and ten incubation 
period distributions, the increase as 
median incubation period increases.
One limitation of this study is that the 
various staging models incorporating 
effect of therapy, different risk groups 
and other methods for reporting delays 
and underreporting were not considered 
due to non-availability and non-
accessibility of the necessary data.  AIDS 
incidence data among all cases reported 
up to Dec. 2002 and diagnosed before Dec. 
2002 were adjusted for reporting delays 
and underreporting and the results were 
compared.  Back-calculat ion was 
performed on the adjusted data using 
f lexible models and conditional  
maximum likelihood estimation method. 
The models used were time variant, 
which allowed for testing availability and 
therapy effects on disease progression. 
The HIV incidence estimates on the 
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cumulative incidences ascertained 
through simulat ion account for  
variability associated with adjustments 
and random components of the models. 
The estimates obtained are lower than the 
estimates given by other international 
bodies  even  a t  ex t reme model  
assumption. Data used consists of 
predominantly adult population for 
back-calculation.  There is an increase in 
trend among the children. The non-
parametric backcalculation approach is 
an alternative which uses mild 
assumptions for projections. 
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